Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia and Google, and an official Content Partner of the New England Journal of Medicine and The Journal of the American Medical Association OpenEvidence is the world’s leading medical information platform.
我们正在追踪 OpenEvidence 的市场扩张
OpenEvidence 的国际扩张与竞争对手的对比情况
OpenEvidence你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 OpenEvidence你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
OpenEvidence at ASCO 2026
已结束
Physicians vote with their feet. OpenEvidence is the most trusted Medical AI among U.S. physicians.
进行中
NBC News: "Almost two-thirds of physicians in the U.S. actively use OpenEvidence, across 27 million clinical encounters last month." "Dr. Eric Rubin, the editor-in-chief of The New England Journal of Medicine, said the relationship between his journal and OpenEvidence was 'deeply symbiotic and a win for patients.'" "Dr. Paul Sax, an infectious disease specialist at Boston’s Brigham and Women’s Hospital, said OpenEvidence often “borders on miraculous,” with its AI-supported search providing custo ...
进行中HLTH 2025展示了医疗保健领域的人工智能进展，包括实际证据整合、主动放射学、MRI模型和临床决策支持。
AI收入集中于少数公司如OpenAI和Anthropic。初创公司超越订阅模式，探索广告模式以实现增长。
Corti推出初创加速计划,为医疗AI创办人提供高达5,000美元信用额度及监管支持,协助应对60万欧元合规障碍,其Symphony模型在医疗基准测试中超越OpenAI。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 OpenEvidence 的业务、市场和增长信号的快速解答。
